Financial statements Biotech Ag
Balance sheet data of BIOTECH AG
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 198 087,45 | 58 467,88 | 679 593,18 | 358 022,76 |
A. Fixed assets | 65 000,00 | 250 272,16 | 336 059,09 | 336 059,09 |
B. Current assets | 133 087,45 | -191 804,28 | 343 534,09 | 21 963,67 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 198 087,45 | 58 467,88 | 679 593,18 | 358 022,76 |
A. Equity | 197 507,58 | -224 939,26 | 99 593,18 | 355 509,06 |
B. Liabilities and provisions for liabilities | 579,87 | 283 407,14 | 580 000,00 | 2 513,70 |
I. Long-term liabilities | - | - | 580 000,00 | 0,00 |
II. Short-term liabilities | - | - | 0,00 | 2 513,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.